Monitoring of circulating tumor DNA allows early detection of disease relapse in patients with operable breast cancer.

Saved in:
Bibliographic Details
Title: Monitoring of circulating tumor DNA allows early detection of disease relapse in patients with operable breast cancer.
Authors: Aanestad KL; Department of Hematology and Oncology, Stavanger University Hospital, Norway., Austdal M; Department of Research, Stavanger University Hospital, Norway., Nordgård O; Department of Hematology and Oncology, Stavanger University Hospital, Norway.; European Liquid Biopsy Society (ELBS), Hamburg, Germany., Mellgren G; Hormone Laboratory, Department of Medical Biochemistry and Pharmacology, Haukeland University Hospital, Bergen, Norway.; Department of Clinical Science, University of Bergen, Norway., Oltedal S; Department of Hematology and Oncology, Stavanger University Hospital, Norway., Austbø ML; Department of Pathology, Stavanger University Hospital, Norway., Vignes YH; Department of Surgery, Stavanger University Hospital, Norway., Helland T; Hormone Laboratory, Department of Medical Biochemistry and Pharmacology, Haukeland University Hospital, Bergen, Norway.; Department of Clinical Science, University of Bergen, Norway., Jonsdottir K; Department of Research, Stavanger University Hospital, Norway., Lende TH; Department of Surgery, Stavanger University Hospital, Norway., Janssen EAM; Department of Pathology, Stavanger University Hospital, Norway.; Department of Chemistry, Bioscience and Environmental Engineering, University of Stavanger, Norway.; Institute for Biomedicine and Glycomics, Griffith University, Australia., Gilje B; Department of Hematology and Oncology, Stavanger University Hospital, Norway., Tjensvoll K; Department of Hematology and Oncology, Stavanger University Hospital, Norway.; European Liquid Biopsy Society (ELBS), Hamburg, Germany.
Corporate Authors: PBCB study group
Source: Molecular oncology [Mol Oncol] 2026 Apr; Vol. 20 (4), pp. 981-994. Date of Electronic Publication: 2025 Nov 27.
Publication Type: Journal Article
Journal Info: Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 101308230 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-0261 (Electronic) Linking ISSN: 15747891 NLM ISO Abbreviation: Mol Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1878-0261
DOI:10.1002/1878-0261.70170